•  
  •  
  •  
  •  

2025-10-10 21:26:29

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Waaree Renewable Technologies Ltd Q2FY26 consolidated net profit rises to Rs. 116.29 crores
  • Affordable Robotic and Automation Ltd Q2 FY2026 consolidated PAT jumps to Rs. 4.56 crores
  • AAA Technologies Ltd posts net profit of Rs. 1.15 crore in Q2 FY26
  • Intense Technologies Ltd Q2 FY2025-26 consolidated net profit up QoQ at Rs. 3.17 crore
  • Vivid Mercantile Ltd Q2 FY2026 PAT lower at Rs. 91.24 lakhs

Keywords Selected:  INE540L01014

Stock Report

  • Alkem launches Pertuza, a pertuzumab biosimilar, in India for treatment of HER2-positive breast cancer
  • Alkem launches Olesoft Trucera, an advanced ceramide-boosting moisturizing lotion for skin barrier repair
  • Alkem Medtech to acquire 100% stake of Bombay Ortho
  • US FDA Inspection at Alkem Laboratories Ltd's Bioequivalence Center located at Taloja
  • Alkem Laboratories launches generic empagliflozin and its combinations in India under the brand name 'Empanorm'
  • Alkem Laboratories enters into a licensing agreement with US-based Sonnet BioTherapeutics
  • Alkem Laboratories denies claims of Pan-D, Clavam 625 batches being not-of-standard quality
  • Closure of US FDA Inspection at Alkem Laboratories Ltd's manufacturing facility located at Baddi, India
  • Alkem Laboratories Ltd receives Form 483 with 10 observations for Baddi facility
  • Closure of US FDA Inspection at Alkem Laboratories Ltd's API manufacturing facility located at Mandva
  • Alkem Laboratories Ltd updates on sale of S&B Pharma LLC's facility
  • Alkem Laboratories Ltd receives 3 observations from USFDA for API manufacturing facility located at Mandva
  • BIOSERGEN, ALKEM collaborate to develop anti-infective for severe fungal infections
  • Alkem Laboratories Ltd recommends final dividend of Rs. 10
  • Closure of US FDA Inspection at Alkem's manufacturing facility located at Indore
  • Alkem Laboratories Ltd declares special dividend of Rs. 25
  • US FDA Inspection at Alkem's manufacturing facility located at Indore
  • US FDA Inspection at Alkem's manufacturing facility located at St. Louis, USA
  • MHRA Inspection at Alkem's Bioequivalence Center at Taloja
  • Alkem Laboratories Ltd board recommends final dividend of Rs. 4
  • US FDA Inspection at Alkem's Bioequivalence Center at Taloja
  • ISP Chile Inspection at Alkem's manufacturing facility located at Baddi, India
  • ISP Chile inspects at Alkem's manufacturing facility located at Daman, India
  • ALKEM licenses technology from Harvard University, aiming to treat ischemic injurv and vascular diseases

Latest Post

  • Waaree Renewable Technologies Ltd Q2FY26 consolidated net profit rises to Rs. 116.29 crores
  • Affordable Robotic and Automation Ltd Q2 FY2026 consolidated PAT jumps to Rs. 4.56 crores
  • AAA Technologies Ltd posts net profit of Rs. 1.15 crore in Q2 FY26
  • Intense Technologies Ltd Q2 FY2025-26 consolidated net profit up QoQ at Rs. 3.17 crore
  • Vivid Mercantile Ltd Q2 FY2026 PAT lower at Rs. 91.24 lakhs


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024